VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 140 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,215,719 | – | 69,430 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 1,314,000 | $15,203,000 | 6.46% |
| Ally Bridge Group (NY) LLC | 496,012 | $5,739,000 | 5.23% |
| VR Adviser, LLC | 1,852,919 | $21,438,000 | 4.22% |
| COMMODORE CAPITAL LP | 1,638,609 | $18,959,000 | 4.01% |
| Ghost Tree Capital, LLC | 600,000 | $6,942,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 1,306,569 | $15,117,000 | 3.01% |
| Fairmount Funds Management LLC | 944,092 | $10,923,000 | 2.50% |
| Kynam Capital Management, LP | 590,143 | $6,828,000 | 1.74% |
| Soleus Capital Management, L.P. | 841,018 | $9,731,000 | 1.52% |
| Vivo Capital, LLC | 1,300,000 | $15,041,000 | 1.51% |